A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana, India.


Journal

The Journal of general virology
ISSN: 1465-2099
Titre abrégé: J Gen Virol
Pays: England
ID NLM: 0077340

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 16 2 2021
medline: 14 4 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing COVID-19 has rapidly turned into a pandemic, infecting millions and causing 1 157 509 (as of 27 October 2020) deaths across the globe. In addition to studying the mode of transmission and evasion of host immune system, analysing the viral mutational landscape constitutes an area under active research. The latter is expected to impart knowledge on the emergence of different clades, subclades, viral protein functions and protein-protein and protein-RNA interactions during replication/transcription cycle of virus and response to host immune checkpoints. In this study, we have attempted to bring forth the viral genomic variants defining the major clade(s) as identified from samples collected from the state of Telangana, India. We further report a comprehensive draft of all genomic variations (including unique mutations) present in SARS-CoV-2 strain in the state of Telangana. Our results reveal the presence of two mutually exclusive subgroups defined by specific variants within the dominant clade present in the population. This work attempts to bridge the critical gap regarding the genomic landscape and associate mutations in SARS-CoV-2 from a highly infected southern region of India, which was lacking to date.

Identifiants

pubmed: 33587028
doi: 10.1099/jgv.0.001562
pmc: PMC8515869
doi:

Substances chimiques

Viral Nonstructural Proteins 0
Viral Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
Cell. 2020 May 14;181(4):914-921.e10
pubmed: 32330414
Cell. 2020 Aug 20;182(4):812-827.e19
pubmed: 32697968
Curr Top Microbiol Immunol. 2005;287:1-30
pubmed: 15609507
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Int J Infect Dis. 2020 Nov;100:112-116
pubmed: 32891737
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
J Mol Evol. 1984;20(1):86-93
pubmed: 6429346
RNA. 2015 May;21(5):877-86
pubmed: 25752599
RNA. 2004 Sep;10(9):1337-51
pubmed: 15273323
Indian J Med Res. 2020 May;151(5):450-458
pubmed: 32474553
Front Microbiol. 2020 Sep 03;11:573430
pubmed: 33013809
Antiviral Res. 2018 Jan;149:58-74
pubmed: 29128390
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Nat Commun. 2020 Nov 26;11(1):6013
pubmed: 33243994
Virus Res. 2008 May;133(2):136-48
pubmed: 18255185
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Osong Public Health Res Perspect. 2020 Feb;11(1):3-7
pubmed: 32149036
Science. 2020 Sep 11;369(6509):1395-1398
pubmed: 32763915
Open Forum Infect Dis. 2020 Sep 18;7(11):ofaa434
pubmed: 33200080
Genomics Proteomics Bioinformatics. 2020 Dec;18(6):749-759
pubmed: 33704069
mSystems. 2020 May 5;5(3):
pubmed: 32371472
Arch Virol. 2021 Mar;166(3):801-812
pubmed: 33464421
J Med Virol. 2020 Jun;92(6):584-588
pubmed: 32083328
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Nat Rev Microbiol. 2009 Jun;7(6):439-50
pubmed: 19430490
J Biosci. 2020;45:
pubmed: 32515358
Mol Cell. 2021 Feb 4;81(3):584-598.e5
pubmed: 33444546
FASEB J. 2019 Aug;33(8):8865-8877
pubmed: 31034780
Lancet Infect Dis. 2020 Sep;20(9):e238-e244
pubmed: 32628905
NAR Genom Bioinform. 2021 May 22;3(2):lqab043
pubmed: 34046592
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
J Virol. 2008 Dec;82(24):12392-405
pubmed: 18842706
Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1629-1635
pubmed: 32333222
Mol Biol Evol. 2020 Aug 1;37(8):2461
pubmed: 32556291
Infection. 2021 Feb;49(1):117-126
pubmed: 33231841
Clin Microbiol Infect. 2020 Jun;26(6):729-734
pubmed: 32234451
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681

Auteurs

Asmita Gupta (A)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

Radhakrishnan Sabarinathan (R)

National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India.

Pratyusha Bala (P)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

Vinay Donipadi (V)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

Divya Vashisht (D)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

Madhumohan Rao Katika (MR)

Nizam's Institute of Medical Sciences, Hyderabad, India.

Manohar Kandakatla (M)

Nizam's Institute of Medical Sciences, Hyderabad, India.

Debashis Mitra (D)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.
Present address: National Centre for Cell Science, Pune, India.

Ashwin Dalal (A)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

Murali Dharan Bashyam (MD)

Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH